Trgovina Lexicon - LXRX CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.05 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Lexicon Pharmaceuticals Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Predhodno. Zapri* | 2.72 |
Odpri* | 2.67 |
Enoletna sprememba* | 50% |
Dnevni razpon* | 2.44 - 2.67 |
Razpon 52 wk | 1.31-3.79 |
Povprečni obseg (10 dni) | 5.05M |
Povprečni obseg (3 meseci) | 29.81M |
Tržna kapitalizacija | 520.35M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 244.85M |
Prihodki | 126.00K |
EPS | -0.63 |
Dividenda (donosnost v %) | N/A |
Beta | 1.27 |
Datum naslednjega zaslužka | Jul 31, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Jun 2, 2023 | 2.72 | -0.03 | -1.09% | 2.75 | 2.77 | 2.64 |
Jun 1, 2023 | 2.68 | 0.00 | 0.00% | 2.68 | 2.70 | 2.54 |
May 31, 2023 | 3.27 | 0.39 | 13.54% | 2.88 | 3.39 | 2.87 |
May 30, 2023 | 2.86 | -0.52 | -15.38% | 3.38 | 3.43 | 2.65 |
May 26, 2023 | 3.14 | 0.12 | 3.97% | 3.02 | 3.20 | 2.90 |
May 25, 2023 | 2.86 | -0.17 | -5.61% | 3.03 | 3.03 | 2.83 |
May 24, 2023 | 2.98 | -0.04 | -1.32% | 3.02 | 3.02 | 2.94 |
May 23, 2023 | 3.02 | -0.16 | -5.03% | 3.18 | 3.27 | 3.02 |
May 22, 2023 | 3.17 | 0.10 | 3.26% | 3.07 | 3.27 | 3.03 |
May 19, 2023 | 2.97 | 0.04 | 1.37% | 2.93 | 3.00 | 2.86 |
May 18, 2023 | 2.86 | -0.04 | -1.38% | 2.90 | 2.91 | 2.76 |
May 17, 2023 | 2.89 | -0.04 | -1.37% | 2.93 | 2.94 | 2.84 |
May 16, 2023 | 2.90 | -0.03 | -1.02% | 2.93 | 2.95 | 2.81 |
May 15, 2023 | 2.94 | 0.06 | 2.08% | 2.88 | 3.01 | 2.84 |
May 12, 2023 | 2.83 | -0.29 | -9.29% | 3.12 | 3.16 | 2.81 |
May 11, 2023 | 3.10 | 0.06 | 1.97% | 3.04 | 3.17 | 2.98 |
May 10, 2023 | 3.03 | -0.13 | -4.11% | 3.16 | 3.16 | 2.91 |
May 9, 2023 | 3.00 | -0.24 | -7.41% | 3.24 | 3.24 | 2.96 |
May 8, 2023 | 3.23 | -0.27 | -7.71% | 3.50 | 3.53 | 3.20 |
May 5, 2023 | 3.45 | 0.36 | 11.65% | 3.09 | 3.75 | 3.05 |
Lexicon Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
Monday, July 31, 2023 | ||
Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Q2 2023 Lexicon Pharmaceuticals Inc Earnings Release Q2 2023 Lexicon Pharmaceuticals Inc Earnings ReleaseForecast -Previous - |
Tuesday, November 7, 2023 | ||
Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Q3 2023 Lexicon Pharmaceuticals Inc Earnings Release Q3 2023 Lexicon Pharmaceuticals Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 0.139 | 0.298 | 23.995 | 322.073 | 63.209 |
Prihodki | 0.139 | 0.298 | 23.995 | 322.073 | 63.209 |
Celotni stroški prihodkov | 0 | 0 | 1.929 | 3.231 | 2.491 |
Bruto dobiček | 0.139 | 0.298 | 22.066 | 318.842 | 60.718 |
Celotni odhodki iz poslovanja | 100.899 | 87.388 | 70.792 | 180.628 | 166.488 |
Celotna prodaja/splošni/upravni stroški Odhodki | 48.083 | 32.342 | 47.23 | 56.835 | 63.754 |
Raziskave in razvoj | 52.816 | 55.046 | 153.621 | 91.924 | 100.243 |
Other Operating Expenses, Total | 0 | 0 | |||
Prihodki iz poslovanja | -100.76 | -87.09 | -46.797 | 141.445 | -103.279 |
Prihodki (odhodki) od obresti, neto Neoperativni | -2.78 | -0.802 | -14.544 | -20.676 | -20.777 |
Drugo, neto | 1.596 | 0.134 | 2.767 | 3.35 | 3.508 |
Čisti dobiček pred obdavčitvijo | -101.944 | -87.758 | -58.574 | 124.119 | -120.548 |
Čisti dobiček po davkih | -101.944 | -87.758 | -58.574 | 130.133 | -120.548 |
Čisti dobiček pred dodatnimi postavkami | -101.944 | -87.758 | -58.574 | 130.133 | -120.548 |
Čisti dobiček | -101.944 | -87.758 | -58.574 | 130.133 | -120.548 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -101.944 | -87.758 | -58.574 | 130.133 | -120.548 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -101.944 | -87.758 | -58.574 | 130.133 | -120.548 |
Popravljen čisti dobiček | -101.944 | -87.758 | -58.574 | 130.133 | -120.548 |
Popravljene ponderirane povprečne delnice | 165.733 | 145.652 | 110.841 | 116.747 | 105.83 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.61511 | -0.60252 | -0.52845 | 1.11466 | -1.13907 |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.61511 | -0.60252 | -1.71924 | 1.2741 | -1.13907 |
Skupaj izredne postavke | 0 | ||||
Nenavadni odhodki (prihodki) | 0 | 0 | -131.988 | 28.638 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 0.024 | 0.028 | 0.039 | 0.035 | 0.037 |
Prihodki | 0.024 | 0.028 | 0.039 | 0.035 | 0.037 |
Celotni stroški prihodkov | |||||
Bruto dobiček | |||||
Celotni odhodki iz poslovanja | 31.166 | 30.306 | 23.134 | 24.042 | 23.417 |
Celotna prodaja/splošni/upravni stroški Odhodki | 19.14 | 16.329 | 12.577 | 10.686 | 8.491 |
Raziskave in razvoj | 12.026 | 13.977 | 10.557 | 13.356 | 14.926 |
Prihodki iz poslovanja | -31.142 | -30.278 | -23.095 | -24.007 | -23.38 |
Prihodki (odhodki) od obresti, neto Neoperativni | -1.821 | -1.103 | -0.864 | -0.703 | -0.11 |
Drugo, neto | 1.029 | 0.887 | 0.572 | 0.123 | 0.014 |
Čisti dobiček pred obdavčitvijo | -31.934 | -30.494 | -23.387 | -24.587 | -23.476 |
Čisti dobiček po davkih | -31.934 | -30.494 | -23.387 | -24.587 | -23.476 |
Čisti dobiček pred dodatnimi postavkami | -31.934 | -30.494 | -23.387 | -24.587 | -23.476 |
Čisti dobiček | -31.934 | -30.494 | -23.387 | -24.587 | -23.476 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -31.934 | -30.494 | -23.387 | -24.587 | -23.476 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -31.934 | -30.494 | -23.387 | -24.587 | -23.476 |
Popravljen čisti dobiček | -31.934 | -30.494 | -23.387 | -24.587 | -23.476 |
Popravljene ponderirane povprečne delnice | 189.014 | 188.98 | 174.904 | 149.616 | 149.15 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.16895 | -0.16136 | -0.13371 | -0.16433 | -0.1574 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.16895 | -0.16136 | -0.13371 | -0.16433 | -0.1574 |
Nenavadni odhodki (prihodki) | 0 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 140.866 | 88.921 | 157.719 | 337.754 | 173.324 |
Denarna sredstva in kratkoročne naložbe | 138.357 | 86.743 | 152.275 | 271.659 | 160.052 |
Denarna sredstva in ustrezniki | 46.345 | 64.065 | 126.263 | 36.112 | 80.386 |
Kratkoročne naložbe | 92.012 | 22.678 | 26.012 | 235.547 | 79.666 |
Celotne terjatve, neto | 0.028 | 0.014 | 0.395 | 56.532 | 5.924 |
Accounts Receivable - Trade, Net | 0.028 | 0.014 | 0.395 | 56.532 | 5.924 |
Prepaid Expenses | 2.481 | 2.164 | 5.049 | 5.32 | 2.668 |
Total Assets | 194.299 | 136.909 | 203.788 | 417.715 | 284.136 |
Property/Plant/Equipment, Total - Net | 4.371 | 3.476 | 1.495 | 15.747 | 15.865 |
Property/Plant/Equipment, Total - Gross | 8.355 | 8.329 | 7.31 | 77.488 | 75.871 |
Accumulated Depreciation, Total | -3.984 | -4.853 | -5.815 | -61.741 | -60.006 |
Goodwill, Net | 44.543 | 44.543 | 44.543 | 44.543 | 44.543 |
Intangibles, Net | 0 | 19.716 | 50.119 | ||
Other Long Term Assets, Total | 4.519 | -0.031 | 0.031 | -0.045 | 0.285 |
Total Current Liabilities | 23.172 | 22.124 | 46.806 | 65.341 | 36.751 |
Accounts Payable | 10.395 | 9.152 | 5.469 | 12.178 | 17.759 |
Accrued Expenses | 12.373 | 10.469 | 29.691 | 42.151 | 14.482 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 11.646 | 11.012 | 1.115 | |
Other Current Liabilities, Total | 0.404 | 2.503 | 0 | 3.395 | |
Total Liabilities | 77.175 | 23.314 | 47.417 | 300.614 | 310.541 |
Total Long Term Debt | 48.579 | 0 | 0 | 234.171 | 243.887 |
Long Term Debt | 48.579 | 0 | 234.171 | 243.887 | |
Deferred Income Tax | 0 | 6.014 | |||
Other Liabilities, Total | 5.424 | 1.19 | 0.611 | 1.102 | 23.889 |
Total Equity | 117.124 | 113.595 | 156.371 | 117.101 | -26.405 |
Common Stock | 0.189 | 0.15 | 0.142 | 0.106 | 0.106 |
Additional Paid-In Capital | 1709.14 | 1608.75 | 1561.1 | 1462.17 | 1447.95 |
Retained Earnings (Accumulated Deficit) | -1589.72 | -1487.78 | -1400.02 | -1341.44 | -1471.58 |
Treasury Stock - Common | -2.061 | -7.518 | -4.843 | -3.817 | -2.876 |
Other Equity, Total | -0.428 | -0.01 | -0.006 | 0.084 | -0.012 |
Total Liabilities & Shareholders’ Equity | 194.299 | 136.909 | 203.788 | 417.715 | 284.136 |
Total Common Shares Outstanding | 188.726 | 148.917 | 141.496 | 106.272 | 105.926 |
Total Inventory | 0 | 4.243 | 4.68 | ||
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 109.546 | 140.866 | 139.063 | 64.898 | 88.431 |
Denarna sredstva in kratkoročne naložbe | 105.937 | 138.357 | 136.203 | 61.968 | 86.502 |
Denarna sredstva in ustrezniki | 26.001 | 46.345 | 18.834 | 21.45 | 59.52 |
Kratkoročne naložbe | 79.936 | 92.012 | 117.369 | 40.518 | 26.982 |
Celotne terjatve, neto | 0.261 | 0.028 | 0.039 | 0.034 | 0.037 |
Accounts Receivable - Trade, Net | 0.261 | 0.028 | 0.039 | 0.034 | 0.037 |
Prepaid Expenses | 3.348 | 2.481 | 2.821 | 2.896 | 1.892 |
Total Assets | 162.716 | 194.299 | 191.685 | 112.325 | 136.178 |
Property/Plant/Equipment, Total - Net | 8.627 | 4.371 | 8.032 | 2.835 | 3.242 |
Property/Plant/Equipment, Total - Gross | 6.303 | 8.355 | 6.109 | 6.105 | 6.104 |
Accumulated Depreciation, Total | -4.096 | -3.984 | -5.177 | -5.07 | -4.962 |
Goodwill, Net | 44.543 | 44.543 | 44.543 | 44.543 | 44.543 |
Other Long Term Assets, Total | 4.519 | 0.047 | 0.049 | -0.038 | |
Total Current Liabilities | 20.371 | 23.172 | 18.445 | 16.862 | 18.905 |
Accounts Payable | 10.311 | 10.395 | 9.427 | 7.347 | 9.321 |
Accrued Expenses | 9.576 | 12.373 | 8.299 | 9.038 | 8.864 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | |||||
Total Liabilities | 74.67 | 77.175 | 47.667 | 41.495 | 43.48 |
Total Long Term Debt | 48.845 | 48.579 | 23.784 | 23.631 | 23.477 |
Other Liabilities, Total | 5.454 | 5.424 | 5.438 | 1.002 | 1.098 |
Total Equity | 88.046 | 117.124 | 144.018 | 70.83 | 92.698 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.19 | 0.189 | 0.189 | 0.15 | 0.15 |
Additional Paid-In Capital | 1712.56 | 1709.14 | 1705.61 | 1608.73 | 1605.9 |
Retained Earnings (Accumulated Deficit) | -1621.65 | -1589.72 | -1559.23 | -1535.84 | -1511.25 |
Treasury Stock - Common | -2.885 | -2.061 | -2.061 | -2.061 | -2.061 |
Other Equity, Total | -0.163 | -0.428 | -0.491 | -0.15 | -0.037 |
Total Liabilities & Shareholders’ Equity | 162.716 | 194.299 | 191.685 | 112.325 | 136.178 |
Total Common Shares Outstanding | 189.562 | 188.726 | 188.726 | 149.626 | 149.594 |
Other Current Liabilities, Total | 0.484 | 0.404 | 0.719 | 0.477 | 0.72 |
Long Term Debt | 48.845 | 48.579 | 23.784 | 23.631 | 23.477 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -101.944 | -87.758 | -58.574 | 130.133 | -120.548 |
Denarna sredstva iz poslovanja | -88.851 | -87.017 | -142.969 | 113.807 | -148.607 |
Denarna sredstva iz poslovanja | 0.427 | 0.292 | 2.934 | 3.654 | 3.683 |
Deferred Taxes | 0 | 0 | -6.014 | 0 | |
Nedenarne postavke | 12.264 | 10.68 | -118.408 | 44.321 | 13.032 |
Denarna sredstva Plačane obresti | 2.289 | 0.799 | 17.353 | 19.211 | 16.465 |
Spremembe v obratnem kapitalu | 0.402 | -10.231 | 31.079 | -58.287 | -44.774 |
Denarna sredstva pri naložbenju | -71.078 | 2.11 | 380.756 | -155.855 | 169.576 |
Kapitalski izdatki | -1.326 | -1.221 | -0.087 | -0.07 | -0.095 |
Celotne druge postavke denarnih tokov pri naložbenju | -69.752 | 3.331 | 380.843 | -155.785 | 169.671 |
Denarna sredstva pri financiranju | 142.209 | 22.709 | -147.636 | -2.226 | -2.244 |
Izdaja (odplačilo) delnic, neto | 93.341 | 34.409 | 68.944 | -0.941 | -0.24 |
Izdaja (odplačilo) dolga, neto | 48.868 | -11.7 | -216.58 | -1.285 | -2.004 |
Neto sprememba denarnih sredstev | -17.72 | -62.198 | 90.151 | -44.274 | 18.725 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -31.934 | -101.944 | -71.45 | -48.063 | -23.476 |
Cash From Operating Activities | -31.613 | -88.851 | -67.282 | -47.843 | -23.421 |
Cash From Operating Activities | 0.112 | 0.427 | 0.324 | 0.216 | 0.109 |
Non-Cash Items | 3.68 | 12.264 | 8.648 | 5.783 | 2.797 |
Cash Interest Paid | 1.556 | 2.289 | 1.281 | 0.634 | 0.085 |
Changes in Working Capital | -3.471 | 0.402 | -4.804 | -5.779 | -2.851 |
Cash From Investing Activities | 12.093 | -71.078 | -95.252 | -18.056 | -4.408 |
Capital Expenditures | -0.248 | -1.326 | -0.08 | -0.076 | -0.076 |
Other Investing Cash Flow Items, Total | 12.341 | -69.752 | -95.172 | -17.98 | -4.332 |
Cash From Financing Activities | -0.824 | 142.209 | 117.303 | 23.284 | 23.284 |
Issuance (Retirement) of Stock, Net | -0.824 | 93.341 | 93.404 | -0.864 | -0.864 |
Issuance (Retirement) of Debt, Net | 0 | 48.868 | 23.899 | 24.148 | 24.148 |
Net Change in Cash | -20.344 | -17.72 | -45.231 | -42.615 | -4.545 |
Deferred Taxes |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Artal International S.C.A. | Investment Advisor | 45.506 | 86262020 | 0 | 2023-03-31 | LOW |
BVF Partners L.P. | Hedge Fund | 8.5192 | 16149179 | 0 | 2023-03-31 | LOW |
Ulys, L.L.C. | Investment Advisor | 2.7979 | 5303814 | 0 | 2022-08-01 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.792 | 5292626 | 43032 | 2023-03-31 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 2.7644 | 5240247 | -11438 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.6709 | 5062976 | -201281 | 2023-03-31 | LOW |
Invus Public Equities Advisors, LLC | Investment Advisor | 1.8549 | 3516214 | 0 | 2023-03-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.6081 | 3048374 | 56229 | 2023-03-31 | LOW |
D. E. Shaw & Co., L.P. | Hedge Fund | 1.5515 | 2940997 | -136976 | 2023-03-31 | LOW |
New Enterprise Associates (NEA) | Venture Capital | 1.2567 | 2382286 | 0 | 2023-03-31 | LOW |
Pinnacle Associates Ltd. | Investment Advisor/Hedge Fund | 1.0235 | 1940224 | 7447 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.9102 | 1725409 | 117468 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.8251 | 1564098 | 47623 | 2023-03-31 | LOW |
Coats Lonnel | Individual Investor | 0.3927 | 744359 | 158356 | 2023-02-28 | LOW |
Fisher Investments | Investment Advisor/Hedge Fund | 0.38 | 720243 | 0 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.3794 | 719182 | 306384 | 2023-03-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.3633 | 688611 | -7329 | 2023-03-31 | LOW |
Parkman Healthcare Partners LLC | Hedge Fund | 0.3563 | 675328 | 254126 | 2023-03-31 | HIGH |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.3561 | 675018 | -19915 | 2023-03-31 | LOW |
Asset Management One Co., Ltd. | Investment Advisor/Hedge Fund | 0.3194 | 605528 | 605528 | 2022-08-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group535K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$113M+
Mesečni obseg naložb
$64M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Lexicon Company profile
O družbi Lexicon
Lexicon Pharmaceuticals, Inc. je biofarmacevtsko podjetje. Osredotoča se na odkrivanje, razvoj in trženje farmacevtskih izdelkov za zdravljenje človeških bolezni. Njegova priprava vključuje sotagliflozin, LX9211 in LX2761. Sotagliflozin je majhna molekularna spojina, ki se daje peroralno in se razvija za zdravljenje srčnega popuščanja in sladkorne bolezni tipa I ter sladkorne bolezni tipa II, srčnega popuščanja in kronične ledvične bolezni. LX9211 je majhna molekularna spojina, ki se daje peroralno in se razvija za zdravljenje nevropatske bolečine. Družba izvaja klinično preskušanje faze II zdravila LX9211 pri diabetični periferni nevropatski bolečini in drugo klinično preskušanje faze II zdravila LX9211 pri postherpetični nevralgiji. LX2761 je majhna molekularna spojina, ki se daje peroralno in je zasnovana tako, da lokalno zavira natrijev-glukozni kotransporter 1 (SGLT1) v gastrointestinalnem traktu brez zaviranja natrijevega-glukoznega kotransporterja 2 (SGLT2) v ledvicah.
Industry: | Bio Therapeutic Drugs |
8800 Technology Forest Place
8800 Technology Forest Place
77381
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 535.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com